Swipe om te navigeren naar een ander artikel
The online version of this article (doi:10.1186/1757-1146-1-9) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
MT conceived and designed the study, undertook all data collection and analysis and wrote the paper. JP supervised the study at all levels from the design stages, interpretation of data through to completion of the paper to which she has given permission for publication. PF has been involved in intellectual discussions with regard to the study throughout, revising the manuscript for important intellectual content and has given approval for the final version to be published. RP has actively participated and supported the conception and design of the study, supervising all the recruitment of the participants actively discussed the interpretation and implications of results and proof read the final paper and given approval for the final version to be published.
To identify the threshold of reduced sensory perception in Type 2 diabetes mellitus (Type 2 DM) using a range of research grade monofilaments.
Three groups of participants were recruited into a between subject, cross-sectional study. Group 1(NEW), persons with Type 2 DM diagnosed for less than 2 years (n = 80); Group 2 (EST) persons with Type 2 DM diagnosed for more than 2 years (n = 91), and Group 3, a Comparison group without Type 2 DM (n = 73), resulted in a total study population, n = 244. Research grade monofilaments (2, 4, 6, 8 and 10-gram) were employed using standardised protocol, at 6 sites on the plantar aspect of both feet. The demographic and anthropometric measures of gender, age, height, weight, body mass index (BMI), blood pressure and duration of Type 2 DM since diagnosis (if applicable) of the participants were analysed.
Perception of the research grade monofilaments differed significantly between the 3 groups (p < 0.05). The 6-gram monofilament was found to be the threshold of normal perception, based on 90% of the Comparison group perceiving the 6-gram monofilament at all sites in contrast to 64% of NEW and 48% of EST groups.
The 6-gram monofilament was identified as the threshold of normal sensory perception. Inability to perceive the 6-gram monofilament indicates, when using the method described in this study, that diminution of sensory perception is evident. Employing a range of monofilaments, 6, 8 and 10-grams in Type 2 DM foot screening would allow the clinical detection of deteriorating sensory perception and enable implementation of foot protection strategies at an earlier stage than is currently practised.
Ward J: New concepts in diabetic neuropathy. Part 1. The condition and its measurement. The Essential Facts. 1997, Scotia Pharmaceuticals Ltd
Franklin GM, Kahn LB, Baxter J, Marshall JA, Hamman RF: Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study. Am J Epidemio. 1990, 131: 633-643.
Rubin RR: Psychotherapy and Counselling in Diabetes Mellitus. Psychology in Diabetes Care. Edited by: Snoek FJ, Skinner TC. 2000, Chichester: John Wiley & Sons Ltd, 235-263. CrossRef
National Collaborating Centre for Primary Care: Clinical Guideline 10: Type 2 diabetes: Prevention and management of foot problems. 2004, National Institute for Clinical Excellence, London
Pfeifer MA, Tanenberg RJ, Holbert D, Schymer MP, Lee L, May K: The Feasibility of using Monofilaments in Clinical Trials for Diabetic Neuropathy. Diabetes. 2000, 49: 166-
Jeng C, Michelson J, Mizel M: Sensory thresholds of normal human feet. Foot Ankle Int. 2000, 21: 501-504. PubMed
Thomson MP: The association of plantar pressure measurements and perception of research grade monofilaments in the feet of human participants with Type 2 diabetes mellitus. PhD thesis. 2006, University of Southampton, School of Health Professions and Rehabilitation Sciences
Holewski JJ, Stess RM, Graf PM, Grunfeld C: Aesthesiometry: quantification of cutaneous pressure sensation in diabetic peripheral neuropathy. J Rehabil Res Dev. 1988, 25: 1-10. PubMed
Thomson MP, Paisey RP, Frost J, Potter J, Taylor P, Bower L: Sensory testing of feet in subjects without diabetes mellitus as a baseline for neuropathy studies. British Journal of Podiatry. 2001, 4: 49-52.
Portney LG, Watkins MP: Foundations of Clinical Research. Applications to Practice. 2000, New Jersey: Prentice Hall Health, 2
Saltzman CL, Rashid R, Hayes A, Fellner C, Fitzpatrick D, Klapach A, Frantz R, Hillis SL: 4.5-Gram monofilament sensation beneath both first metatarsal heads indicates protective foot sensation in diabetic patients. J Bone Joint Surg Am. 2004, 86-A (4): 717-723. PubMed
Caddick SL, Ibrahim S, Ward JD: The Management of Diabetic Neuropathy. Diabetic Neuropathy. Edited by: Boulton AJM. 1997, Chichester: Marius Press, 147-157.
Diabetes NSF Team: National Service framework for Diabetes. 2001, London, Department of Health
Netten A, Curts L: Unit Costs of Health and Social Care. Personal Social Services Research Unit, University of Kent, Canterbury 2001. The healthcare costs of diabetic peripheral neuropathy in the UK. Diabetic Foot. Edited by: Gordois A, Scuffham P, Shearer A, Oglesby A. 2003, 6: 62-73.
British Medical Association and Royal Pharmaceutical Society of Great Britain, London: British National Formulary 43, March 2002. The healthcare costs of diabetic peripheral neuropathy in the UK. Diabetic Foot. Edited by: Gordois A, Scuffham P, Shearer A, Oglesby A. 2003, 62-73.
The International Working Group on the Diabetic Foot: International Consensus on the Diabetic Foot. 1999, Amsterdam
Daube JR: Electrophysiologic Testing in Diabetic Neuropathy. Diabetic Neuropathy. Edited by: Dyck PJ, Thomas PK. 1999, Philadelphia W B Saunders Company, 222-238.
- Threshold for detection of diabetic peripheral sensory neuropathy using a range of research grade monofilaments in persons with Type 2 diabetes mellitus
Mary P Thomson
Paul M Finch
Richard B Paisey
- BioMed Central